25 May 2026Open access
Signaling pathways driving multiple sclerosis: From mechanisms to natural‑product interventionsBiomedicine & Pharmacotherapy, Multiple Sclerosis Research Studies
UniversitiesHeba Nasr Shalaby
Active, last published 2026
In adenosine and purinergic signaling
Heba Nasr
Shalaby
Scholar“Research focused on Adenosine and Purinergic Signaling and adjacent fields.”
Cairo University
Claim Your Profile3
H-index
53
Citations
Heba has not officially claimed their profile. If you are Heba, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
01 · About the work
What I study
eba Nasr Shalaby is a researcher working on Adenosine and Purinergic Signaling. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Heba's work has been cited 53 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Adenosine and Purinergic Signaling×3Neuroscience and Neuropharmacology Research×2Pain Mechanisms and Treatments×2Regulation of Appetite and Obesity×2Ion channel regulation and function×2
04 · Where I am
Affiliations
Affiliation on published researchCairo UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
7 works6 May 2026Open access
PEGylated Flavonoid Aspasomes as a Brain-Targeted Nano-Vesicular Platform for Enhanced Neuroprotection in Stress-Induced Cognitive DysfunctionAAPS PharmSciTech, Advanced Drug Delivery Systems
1 May 2026
Kv1.3 Channel Blockade by Dalfampridine Attenuates NLRP3 Inflammasome‐Driven Demyelination via the NEK7/Ripk1/FADD Pathway, Matching the Efficacy of Broad P2X7 Antagonism by Suramin in EAEDrug Development Research, Inflammasome and immune disorders
19 Apr 2026
Leptin-driven microglial activation in fibromyalgia: mechanistic insights and therapeutic implicationsInternational Immunopharmacology, Fibromyalgia and Chronic Fatigue Syndrome Research
4 Apr 2026
Anti-inflammatory and antinociceptive effects of fasudil in a reserpine-induced fibromyalgia model: Role of ROCK-regulated leptin–STAT3 signalingLife Sciences, Fibromyalgia and Chronic Fatigue Syndrome Research
1 Apr 2025Open access3cites
Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus‐Induced Nephrotoxicity Through Targeting the miR‐22/HMGB‐1/TLR4/MyD88/NF‐κB TrajectoryArchiv der Pharmazie, Adenosine and Purinergic Signaling
1 Jan 2025Open access2cites
Donepezil-based rational design of <i>N</i>-substituted quinazolinthioacetamide candidates as potential acetylcholine esterase inhibitors for the treatment of Alzheimer's disease: <i>in vitro</i> and <i>in vivo</i> studiesRSC Medicinal Chemistry, Computational Drug Discovery Methods
Are you Heba?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required